Cytotoxic CD4+ targeting viral antigens [53–55] and alloantigens [56–58] have been described previously, but in these models, the influence of Tregs on effector CD4+ T-cell activity was not investigated but the tumor or the pathogen was eliminated by adoptive transfer of effector CD4+ T cells [57, 59]. The gene discussed is CD4; the disease is neoplasm.